{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:32:19Z","timestamp":1784770339449,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00380-023-02318-w","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T16:02:04Z","timestamp":1695830524000},"page":"144-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-2406","authenticated-orcid":false,"given":"Olena","family":"Pankova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-4360","authenticated-orcid":false,"given":"Oleksii","family":"Korzh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"2318_CR1","unstructured":"World Health Organization (2020) Global health estimates 2019 Summary tables: deaths by cause, age and sex, by world bank income group, 2000\u20132019. https:\/\/www.who.int\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_cod_wbincome_2000_201933383745-a750-4d94-8491-fb209dcece6f.xlsx?sfvrsn=e7bafa8_5). Accessed 10 May 2023."},{"issue":"10159","key":"2318_CR2","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"GBD 2017 Risk Factor Collaborators","year":"2018","unstructured":"GBD 2017 Risk Factor Collaborators (2018) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 392(10159):1923\u20131994","journal-title":"Lancet"},{"issue":"1","key":"2318_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.numecd.2021.09.007","volume":"32","author":"H Al Ghorani","year":"2022","unstructured":"Al Ghorani H, G\u00f6tzinger F, B\u00f6hm M, Mahfoud F (2022) Arterial hypertension\u2014clinical trials update 2021. Nutr Metab Cardiovasc Dis 32(1):21\u201331","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"2318_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.pcd.2020.11.001","volume":"15","author":"T Sabuncu","year":"2021","unstructured":"Sabuncu T, Sonmez A, Eren MA, Sahin I, \u00c7orap\u00e7io\u011flu D, \u00dc\u00e7ler R, Akin \u015e, Haymana C, Demirci \u0130, Atmaca A, Ers\u00f6z H\u00d6, Satman I, Bayram F, TEMD Study Group (2021) Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. results from the Turkish nationwide SurvEy of glycemic and other metabolic parameters of patients with diabetes mellitus (TEMD hypertension study). Prim Care Diabetes 15(2):332\u2013339","journal-title":"Prim Care Diabetes"},{"issue":"5","key":"2318_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM (2018) Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 34(5):575\u2013584","journal-title":"Can J Cardiol"},{"key":"2318_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.maturitas.2018.03.013","volume":"112","author":"DI Pavlou","year":"2018","unstructured":"Pavlou DI, Paschou SA, Anagnostis P, Spartalis M, Spartalis E, Vryonidou A, Tentolouris N, Siasos G (2018) Hypertension in patients with type 2 diabetes mellitus: targets and management. Maturitas 112:71\u201377","journal-title":"Maturitas"},{"issue":"12","key":"2318_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1080\/14779072.2018.1540301","volume":"16","author":"T Saxena","year":"2018","unstructured":"Saxena T, Ali AO, Saxena M (2018) Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther 16(12):879\u2013887","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"2318_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s11883-012-0227-2","volume":"14","author":"BM Cheung","year":"2012","unstructured":"Cheung BM, Li C (2012) Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep 14(2):160\u2013166","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"2318_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12933-021-01356-w","volume":"20","author":"P Valensi","year":"2021","unstructured":"Valensi P (2021) Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications. Cardiovasc Diabetol 20(1):170","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2318_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui L (2014) Energy metabolism in the liver. Compr Physiol 4(1):177\u2013197","journal-title":"Compr Physiol"},{"issue":"1","key":"2318_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.regpep.2010.09.007","volume":"165","author":"SK Mahata","year":"2010","unstructured":"Mahata SK, Mahata M, Fung MM, O\u2019Connor DT (2010) Reprint of: Catestatin: a multifunctional peptide from chromogranin A. Regul Pept 165(1):52\u201362","journal-title":"Regul Pept"},{"issue":"6","key":"2318_CR12","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1172\/JCI119686","volume":"100","author":"SK Mahata","year":"1997","unstructured":"Mahata SK, O\u2019Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ (1997) Novel autocrine feedback control of catecholamine release a discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100(6):1623\u20131633","journal-title":"J Clin Invest"},{"issue":"7","key":"2318_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/00004872-200207000-00020","volume":"20","author":"DT O\u2019Connor","year":"2002","unstructured":"O\u2019Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ (2002) Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20(7):1335\u20131345","journal-title":"J Hypertens"},{"issue":"11","key":"2318_CR14","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1210\/en.2009-0429","volume":"150","author":"JR Gayen","year":"2009","unstructured":"Gayen JR, Gu Y, O\u2019Connor DT, Mahata SK (2009) Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin A null mouse. Endocrinology 150(11):5027\u20135035","journal-title":"Endocrinology"},{"issue":"7","key":"2318_CR15","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1172\/JCI24354","volume":"115","author":"NR Mahapatra","year":"2005","unstructured":"Mahapatra NR, O\u2019Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115(7):1942\u20131952","journal-title":"J Clin Invest"},{"issue":"5","key":"2318_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/HYPERTENSIONAHA.120.16809","volume":"77","author":"W Ying","year":"2021","unstructured":"Ying W, Tang K, Avolio E, Schilling JM, Pasqua T, Liu MA, Cheng H, Gao H, Zhang J, Mahata S, Ko MS, Bandyopadhyay G, Das S, Roth DM, Sahoo D, Webster NJG, Sheikh F, Ghosh G, Patel HH, Ghosh P, van den Bogaart G, Mahata SK (2021) Immunosuppression of macrophages underlies the cardioprotective effects of CST (catestatin). Hypertension 77(5):1670\u20131682","journal-title":"Hypertension"},{"key":"2318_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2014.04.001","volume":"270","author":"E Avolio","year":"2014","unstructured":"Avolio E, Mahata SK, Mantuano E, Mele M, Al\u00f2 R, Facciolo RM, Talani G, Canonaco M (2014) Antihypertensive and neuroprotective effects of catestatin in spontaneously hypertensive rats: interaction with GABAergic transmission in amygdala and brainstem. Neuroscience 270:48\u201357","journal-title":"Neuroscience"},{"issue":"3","key":"2318_CR18","doi-asserted-by":"publisher","first-page":"R365","DOI":"10.1152\/ajpregu.00409.2011","volume":"302","author":"AH Gaede","year":"2012","unstructured":"Gaede AH, Pilowsky PM (2012) Catestatin, a chromogranin A-derived peptide, is sympathoinhibitory and attenuates sympathetic barosensitivity and the chemoreflex in rat CVLM. Am J Physiol Regul Integr Comp Physiol 302(3):R365\u2013R372","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"2318_CR19","doi-asserted-by":"publisher","first-page":"R1538","DOI":"10.1152\/ajpregu.00335.2010","volume":"299","author":"AH Gaede","year":"2010","unstructured":"Gaede AH, Pilowsky PM (2010) Catestatin in rat RVLM is sympathoexcitatory, increases barosensitivity, and attenuates chemosensitivity and the somatosympathetic reflex. Am J Physiol Regul Integr Comp Physiol 299(6):R1538\u2013R1545","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2318_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.niox.2015.07.004","volume":"50","author":"T Angelone","year":"2015","unstructured":"Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC (2015) The NO stimulator, catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide 50:10\u201319","journal-title":"Nitric Oxide"},{"issue":"7","key":"2318_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0196-9781(98)00086-2","volume":"19","author":"BP Kennedy","year":"1998","unstructured":"Kennedy BP, Mahata SK, O\u2019Connor DT, Ziegler MG (1998) Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides 19(7):1241\u20131248","journal-title":"Peptides"},{"key":"2318_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1749-6632.2002.tb04493.x","volume":"971","author":"PG Kr\u00fcger","year":"2002","unstructured":"Kr\u00fcger PG, Mahata SK, Helle KB (2002) Catestatin (chromograninA344-358) stimulates release of histamine from rat pleural and peritoneal mast cells. Ann N Y Acad Sci 971:349\u2013351","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2318_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3390\/biom12091204","volume":"12","author":"M Kumric","year":"2022","unstructured":"Kumric M, Vrdoljak J, Dujic G, Supe-Domic D, Ticinovic Kurir T, Dujic Z, Bozic J (2022) Serum catestatin levels correlate with ambulatory blood pressure and indices of arterial stiffness in patients with primary hypertension. Biomolecules 12(9):1204","journal-title":"Biomolecules"},{"issue":"9","key":"2318_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2459\/JCM.0b013e328346c142","volume":"12","author":"L Meng","year":"2011","unstructured":"Meng L, Ye XJ, Ding WH, Yang Y, Di BB, Liu L, Huo Y (2011) Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension. J Cardiovasc Med 12(9):643\u2013647","journal-title":"J Cardiovasc Med"},{"key":"2318_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.5152\/akd.2014.5536","volume":"15","author":"ME Durako\u011flugil","year":"2015","unstructured":"Durako\u011flugil ME, Ayaz T, Kocaman SA, K\u0131rba\u015f A, Durako\u011flugil T, Erdo\u011fan T, \u00c7etin M, \u015eahin OZ, \u00c7i\u00e7ek Y (2015) The relationship of plasma catestatin concentrations with metabolic and vascular parameters in untreated hypertensive patients: influence on high-density lipoprotein cholesterol. Anatol J Cardiol 15:577\u2013585","journal-title":"Anatol J Cardiol"},{"issue":"33","key":"2318_CR26","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group (2018) 2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur Heart J 39(33):3021\u20133104","journal-title":"Eur Heart J"},{"key":"2318_CR27","first-page":"1","volume":"854","author":"World Health Organization","year":"1995","unstructured":"World Health Organization (1995) Physical status: the use and interpretation of anthropometry. report of a WHO expert committee. World Health Organ Tech Rep Ser 854:1\u2013452","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2318_CR28","unstructured":"World Health Organization. Noncommunicable Diseases and Mental Health Cluster (2020) WHO STEPS Surveillance manual: the WHO STEPwise approach to noncommunicable disease risk factor surveillance. https:\/\/www.who.int\/docs\/default-source\/ncds\/ncd-surveillance\/steps\/steps-manual.pdf?sfvrsn=c281673d_5. Accessed 02 May 2023."},{"issue":"1","key":"2318_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2337\/cd22-as01","volume":"40","author":"American Diabetes Association","year":"2022","unstructured":"American Diabetes Association (2022) Standards of medical care in diabetes-2022 abridged for primary care providers. Clin Diabetes 40(1):10\u201338","journal-title":"Clin Diabetes"},{"issue":"i-xii","key":"2318_CR30","first-page":"1","volume":"894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic report of a WHO consultation. World Health Organ Tech Rep Ser 894(i\u2013xii):1\u2013253","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"1","key":"2318_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter 3(1):1\u2013150","journal-title":"Kidney Inter"},{"issue":"1","key":"2318_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and European atherosclerosis society (EAS). Eur Heart J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"3","key":"2318_CR33","first-page":"41","volume":"6","author":"EY Gubareva","year":"2018","unstructured":"Gubareva EY, Kryukov NN, Gubareva IV, Zheltyakova OV, Martynenko ID (2018) The catestatin role in the formation of arterial pressure circadian profile in patients with essential hypertension. Cardiol News Opin Train 6(3):41\u201350 (in Russian)","journal-title":"Cardiol News Opin Train"},{"key":"2318_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2459\/JCM.0b013e328348d925","volume":"12","author":"G Schillaci","year":"2011","unstructured":"Schillaci G, De Vuono S, Pucci G (2011) An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension. J Cardiovasc Med 12:609\u2013612","journal-title":"J Cardiovasc Med"},{"issue":"3","key":"2318_CR35","first-page":"214","volume":"32","author":"L Ding","year":"2016","unstructured":"Ding L, Zheng QQ, Li Y, Chen XY, Chen R, Wang XR, Gong YS, Fan XF (2016) Role of catestatin in 2K1C-induced renal hypertension in rats and the underlying mechanism. Zhongguo Ying Yong Sheng Li Xue Za Zhi 32(3):214\u2013218 (in Chinese)","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"3","key":"2318_CR36","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1681\/ASN.2007070754","volume":"19","author":"RM Salem","year":"2008","unstructured":"Salem RM, Cadman PE, Chen Y, Rao F, Wen G, Hamilton BA, Rana BK, Smith DW, Stridsberg M, Ward HJ, Mahata M, Mahata SK, Bowden DW, Hicks PJ, Freedman BI, Schork NJ, O\u2019Connor DT (2008) Chromogranin a polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol 19(3):600\u2013614","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2318_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1160\/TH17-05-0349","volume":"118","author":"M Kojima","year":"2018","unstructured":"Kojima M, Ozawa N, Mori Y, Takahashi Y, Watanabe-Kominato K, Shirai R, Watanabe R, Sato K, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T (2018) Catestatin prevents macrophage-driven atherosclerosis but not arterial injury\u2013induced neointimal hyperplasia. Thromb Haemost 118(1):182\u2013194","journal-title":"Thromb Haemost"},{"key":"2318_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2018.12.025","volume":"281","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wang X, Yang C, Su X, Yang W, Dai Y, Han H, Jiang J, Lu L, Wang H, Chen Q, Jin W (2019) Decreased circulating catestatin levels are associated with coronary artery disease: the emerging anti-inflammatory role. Atherosclerosis 281:78\u201388","journal-title":"Atherosclerosis"},{"issue":"3","key":"2318_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000448987","volume":"136","author":"W Xu","year":"2017","unstructured":"Xu W, Yu H, Wu H, Li S, Chen B, Gao W (2017) Plasma catestatin in patients with acute coronary syndrome. Cardiology 136(3):164\u2013169","journal-title":"Cardiology"},{"key":"2318_CR40","doi-asserted-by":"publisher","first-page":"44168","DOI":"10.1038\/srep44168","volume":"7","author":"D Zhu","year":"2017","unstructured":"Zhu D, Xie H, Wang X, Liang Y, Yu H, Gao W (2017) Catestatin-a novel predictor of left ventricular remodeling after acute myocardial infarction. Sci Rep 7:44168","journal-title":"Sci Rep"},{"issue":"4","key":"2318_CR41","doi-asserted-by":"publisher","first-page":"e0122993","DOI":"10.1371\/journal.pone.0122993","volume":"10","author":"D Zhu","year":"2015","unstructured":"Zhu D, Xie H, Wang X, Liang Y, Yu H, Gao W (2015) Correlation of plasma catestatin level and the prognosis of patients with acute myocardial infarction. PLoS ONE 10(4):e0122993","journal-title":"PLoS ONE"},{"issue":"4","key":"2318_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/1354750X.2011.578260","volume":"16","author":"X Wang","year":"2011","unstructured":"Wang X, Xu S, Liang Y, Zhu D, Mi L, Wang G, Gao W (2011) Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction. Biomarkers 16(4):372\u2013377","journal-title":"Biomarkers"},{"issue":"1050","key":"2318_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/postgradmedj-2012-131060","volume":"89","author":"L Meng","year":"2013","unstructured":"Meng L, Wang J, Ding WH, Han P, Yang Y, Qi LT, Zhang BW (2013) Plasma catestatin level in patients with acute myocardial infarction and its correlation with ventricular remodelling. Postgrad Med J 89(1050):193\u2013196","journal-title":"Postgrad Med J"},{"issue":"4","key":"2318_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/14017431.2013.794951","volume":"47","author":"L Liu","year":"2013","unstructured":"Liu L, Ding W, Zhao F, Shi L, Pang Y, Tang C (2013) Plasma levels and potential roles of catestatin in patients with coronary heart disease. Scand Cardiovasc J 47(4):217\u2013224","journal-title":"Scand Cardiovasc J"},{"issue":"ehab724","key":"2318_CR45","first-page":"2280","volume":"42","author":"E Gubareva","year":"2021","unstructured":"Gubareva E, Gubareva I (2021) Catestatin in patients with essential hypertension of different cardiovascular risk. Eur Heart J 42(ehab724):2280","journal-title":"Eur Heart J"},{"issue":"3","key":"2318_CR46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.31688\/ABMU.2019.54.3.15","volume":"54","author":"O Korzh","year":"2019","unstructured":"Korzh O, Krasnokutskiy S, Pankova O (2019) Improving the drug compliance of hypertensive patients in primary care: importance of health education and self-management. Arch Balk Med Union 54(3):497\u2013502","journal-title":"Arch Balk Med Union"},{"key":"2318_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.peptides.2013.05.003","volume":"46","author":"L Liu","year":"2013","unstructured":"Liu L, Ding W, Li R, Ye X, Zhao J, Jiang J, Meng L, Wang J, Chu S, Han X, Peng F (2013) Plasma levels and diagnostic value of catestatin in patients with heart failure. Peptides 46:20\u201325","journal-title":"Peptides"},{"issue":"1","key":"2318_CR48","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1038\/s41598-022-07735-x","volume":"12","author":"P Simac","year":"2022","unstructured":"Simac P, Perkovic D, Bozic I, Matijas M, Gugo K, Martinovic D, Bozic J (2022) Serum catestatin levels in patients with rheumatoid arthritis. Sci Rep 12(1):3812","journal-title":"Sci Rep"},{"issue":"1","key":"2318_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1378\/chest.09-2832","volume":"138","author":"J Kim","year":"2010","unstructured":"Kim J, Lee S, Bhattacharjee R, Khalyfa A, Kheirandish-Gozal L, Gozal D (2010) Leukocyte telomere length and plasma catestatin and myeloid-related protein 8\/14 concentrations in children with obstructive sleep apnea. Chest 138(1):91\u201399","journal-title":"Chest"},{"issue":"1","key":"2318_CR50","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12884-021-04139-z","volume":"21","author":"M Bralewska","year":"2021","unstructured":"Bralewska M, Biesiada L, Grzesiak M, Rybak-Krzyszkowska M, Huras H, Gach A, Pietrucha T, Sakowicz A (2021) Chromogranin A demonstrates higher expression in preeclamptic placentas than in normal pregnancy. BMC Pregnancy Childbirth 21(1):680","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"2318_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/01443615.2021.1873922","volume":"42","author":"N T\u00fcten","year":"2022","unstructured":"T\u00fcten N, G\u00fcralp O, G\u00f6k K, Hamzaoglu K, Oner YO, Makul M, Bulut H, Irmak K, T\u00fcten A, Malik E (2022) Serum catestatin level is increased in women with preeclampsia. J Obstet Gynaecol 42(1):55\u201360","journal-title":"J Obstet Gynaecol"},{"issue":"4","key":"2318_CR52","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4274\/tjod.galenos.2021.34946","volume":"18","author":"M \u00d6zalp","year":"2021","unstructured":"\u00d6zalp M, Yaman H, Demir \u00d6, Aytekin Garip S, Aran T, Osmana\u011fao\u011flu MA (2021) The role of maternal serum catestatin in the evaluation of preeclampsia and fetal cardiac functions. Turk J Obstet Gynecol 18(4):272\u2013278","journal-title":"Turk J Obstet Gynecol"},{"issue":"2","key":"2318_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11325-018-1703-x","volume":"23","author":"JA Borovac","year":"2019","unstructured":"Borovac JA, Dogas Z, Supe-Domic D, Galic T, Bozic J (2019) Catestatin serum levels are increased in male patients with obstructive sleep apnea. Sleep Breath 23(2):473\u2013481","journal-title":"Sleep Breath"},{"issue":"5","key":"2318_CR54","first-page":"549","volume":"20","author":"M Simunovic","year":"2019","unstructured":"Simunovic M, Supe-Domic D, Karin Z, Degoricija M, Paradzik M, Bozic J, Unic I, Skrabic V (2019) Serum catestatin concentrations are decreased in obese children and adolescents. Pediatr Diabetes 20(5):549\u2013555","journal-title":"Pediatr Diabetes"},{"key":"2318_CR55","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/jcm9030628","volume":"9","author":"PM Zivkovic","year":"2020","unstructured":"Zivkovic PM, Matetic A, Tadin Hadjina I, Rusic D, Vilovic M, Supe-Domic D, Borovac JA, Mudnic I, Tonkic A, Bozic J (2020) Serum catestatin levels and arterial stiffness parameters are increased in patients with inflammatory bowel disease. J Clin Med 9:628","journal-title":"J Clin Med"},{"issue":"2","key":"2318_CR56","doi-asserted-by":"publisher","first-page":"e13655","DOI":"10.1111\/apha.13655","volume":"232","author":"EM Muntjewerff","year":"2021","unstructured":"Muntjewerff EM, Tang K, Lutter L, Christoffersson G, Nicolasen MJT, Gao H, Katkar GD, Das S, Ter Beest M, Ying W, Ghosh P, El Aidy S, Oldenburg B, van den Bogaart G, Mahata SK (2021) Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides. Acta Physiol 232(2):e13655","journal-title":"Acta Physiol"},{"issue":"8","key":"2318_CR57","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/jcm8081132","volume":"8","author":"JA Borovac","year":"2019","unstructured":"Borovac JA, Glavas D, Susilovic Grabovac Z, Supe-Domic D, D\u2019Amario D, Bozic J (2019) Catestatin in acutely decompensated heart failure patients: insights from the CATSTAT-HF study. J Clin Med 8(8):1132","journal-title":"J Clin Med"},{"issue":"5","key":"2318_CR58","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2337\/db17-0788","volume":"67","author":"W Ying","year":"2018","unstructured":"Ying W, Mahata S, Bandyopadhyay GK, Zhou Z, Wollam J, Vu J, Mayoral R, Chi NW, Webster NJG, Corti A, Mahata SK (2018) Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production leading to improved insulin sensitivity. Diabetes 67(5):841\u2013848","journal-title":"Diabetes"},{"issue":"1","key":"2318_CR59","doi-asserted-by":"publisher","first-page":"e13775","DOI":"10.1111\/apha.13775","volume":"235","author":"G Bandyopadhyay","year":"2022","unstructured":"Bandyopadhyay G, Tang K, Webster NJG, van den Bogaart G, Mahata SK (2022) Catestatin induces glycogenesis by stimulating the phosphoinositide 3-kinase-AKT pathway. Acta Physiol 235(1):e13775","journal-title":"Acta Physiol"},{"key":"2318_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.csbj.2020.02.005","volume":"18","author":"A Dasgupta","year":"2020","unstructured":"Dasgupta A, Bandyopadhyay GK, Ray I, Bandyopadhyay K, Chowdhury N, De RK, Mahata SK (2020) Catestatin improves insulin sensitivity by attenuating endoplasmic reticulum stress: in vivo and in silico validation. Comput Struct Biotechnol J 18:464\u2013481","journal-title":"Comput Struct Biotechnol J"},{"key":"2318_CR61","doi-asserted-by":"publisher","first-page":"2086109","DOI":"10.1155\/2018\/2086109","volume":"2018","author":"MP Gallo","year":"2018","unstructured":"Gallo MP, Femmin\u00f2 S, Antoniotti S, Querio G, Alloatti G, Levi R (2018) Catestatin induces glucose uptake and GLUT4 trafficking in adult rat cardiomyocytes. Biomed Res Int 2018:2086109","journal-title":"Biomed Res Int"},{"issue":"3","key":"2318_CR62","first-page":"453","volume":"92","author":"DT Li","year":"2019","unstructured":"Li DT, Habtemichael EN, Julca O, Sales CI, Westergaard XO, DeVries SG, Ruiz D, Sayal B, Bogan JS (2019) GLUT4 storage vesicles: specialized organelles for regulated trafficking. Yale J Biol Med 92(3):453\u2013470","journal-title":"Yale J Biol Med"},{"key":"2318_CR63","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2022.36.S1.R3297","author":"SK Mahata","year":"2022","unstructured":"Mahata SK, Mahata S, Pasqua T, Avolio E, Tang K, Bandyopadhyay G, Webster NJG (2022) Catestatin regulates core bioenergetic and metabolic functions of the myocardium. FASEB J. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.R3297","journal-title":"FASEB J"},{"issue":"27","key":"2318_CR64","doi-asserted-by":"publisher","first-page":"23141","DOI":"10.1074\/jbc.M111.335877","volume":"287","author":"GK Bandyopadhyay","year":"2012","unstructured":"Bandyopadhyay GK, Vu CU, Gentile S, Lee H, Biswas N, Chi NW, O\u2019Connor DT, Mahata SK (2012) Catestatin (chromogranin A352\u2013372) and novel effects on mobilization of fat from adipose tissue through regulation of adrenergic and leptin signaling. J Biol Chem 287(27):23141\u201323151","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2318_CR65","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11010-007-9447-0","volume":"302","author":"PB Verghese","year":"2007","unstructured":"Verghese PB, Arrese EL, Soulages JL (2007) Stimulation of lipolysis enhances the rate of cholesterol efflux to HDL in adipocytes. Mol Cell Biochem 302(1\u20132):241\u2013248","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"2318_CR66","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/CIRCULATIONAHA.109.897330","volume":"121","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, McGillicuddy FC, Hinkle CC, O\u2019Neill S, Glick JM, Rothblat GH, Reilly MP (2010) Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 121(11):1347\u20131355","journal-title":"Circulation"},{"issue":"2","key":"2318_CR67","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI (2022) metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786","journal-title":"Int J Mol Sci"},{"key":"2318_CR68","doi-asserted-by":"publisher","first-page":"m4266","DOI":"10.1136\/bmj.m4266","volume":"371","author":"CDL Johannesen","year":"2020","unstructured":"Johannesen CDL, Langsted A, Mortensen MB, Nordestgaard BG (2020) Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ 371:m4266","journal-title":"BMJ"},{"issue":"1","key":"2318_CR69","first-page":"36","volume":"62","author":"MR Hingorjo","year":"2012","unstructured":"Hingorjo MR, Qureshi MA, Mehdi A (2012) Neck circumference as a useful marker of obesity: a comparison with body mass index and waist circumference. J Pak Med Assoc 62(1):36\u201340","journal-title":"J Pak Med Assoc"},{"issue":"10","key":"2318_CR70","first-page":"e30750","volume":"14","author":"H Kamarli Altun","year":"2022","unstructured":"Kamarli Altun H, Suna G (2022) Is neck circumference related to other anthropometric measurements and biochemical parameters in type 2 diabetes? Cureus 14(10):e30750","journal-title":"Cureus"},{"issue":"3","key":"2318_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Despr\u00e9s JP (2020) Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol 16(3):177\u2013189","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2318_CR72","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1186\/s12889-021-12371-7","volume":"21","author":"P Mousapour","year":"2021","unstructured":"Mousapour P, Barzin M, Valizadeh M, Mahdavi M, Hadaegh F, Azizi F, Hosseinpanah F (2021) Wrist circumference as a novel predictor of transition from metabolically healthy to unhealthy phenotype in overweight\/obese adults: a gender-stratified 15.5-year follow-up. BMC Public Health 21(1):2276","journal-title":"BMC Public Health"},{"issue":"1","key":"2318_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","volume":"23","author":"C Pic\u00f3","year":"2022","unstructured":"Pic\u00f3 C, Palou M, Pomar CA, Rodr\u00edguez AM, Palou A (2022) Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord 23(1):13\u201330","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"2318_CR74","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/biom11030456","volume":"11","author":"M Luketin","year":"2021","unstructured":"Luketin M, Mizdrak M, Boric-Skaro D, Martinovic D, Tokic D, Vilovic M, Supe-Domic D, Ticinovic Kurir T, Bozic J (2021) Plasma catestatin levels and advanced glycation end products in patients on hemodialysis. Biomolecules 11(3):456","journal-title":"Biomolecules"},{"key":"2318_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.peptides.2014.02.016","volume":"55","author":"Z Pei","year":"2014","unstructured":"Pei Z, Ma D, Ji L, Zhang J, Su J, Xue W, Chen X, Wang W (2014) Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction. Peptides 55:131\u2013135","journal-title":"Peptides"},{"issue":"1","key":"2318_CR76","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/life11010053","volume":"11","author":"M Kumri\u0107","year":"2021","unstructured":"Kumri\u0107 M, Borovac JA, Kurir TT, Bo\u017ei\u0107 J (2021) Clinical implications of uric acid in heart failure: a comprehensive review. Life 11(1):53","journal-title":"Life"},{"issue":"6","key":"2318_CR77","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/HYPERTENSIONAHA.117.09081","volume":"69","author":"C Borghi","year":"2017","unstructured":"Borghi C, Cicero AFG (2017) Serum uric acid and cardiometabolic disease: another brick in the wall? Hypertension 69(6):1011\u20131013","journal-title":"Hypertension"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-023-02318-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-023-02318-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-023-02318-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T10:03:35Z","timestamp":1704967415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-023-02318-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2318"],"URL":"https:\/\/doi.org\/10.1007\/s00380-023-02318-w","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with all ethical principles of the Seventh Revision of the Helsinki Declaration from 2013. The study protocol was approved by the Ethics Committee of the Medical-Sanitary Base of JSC \u201cKharkiv Tractor Plant\u201d (date of approval: 21 September 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each patient was informed about the objectives, course, approximate duration, procedures, benefits and possible risks of the present study. All study participants signed a written informed consent prior to any protocol procedures and enrollment in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}